In addition, IgG antibodies elicited by H3 viruses and/or IL-15 broadly bound to influenza HAs from both group 1 and group 2 influenza strains, which suggests potential use of CpG adjuvants and/or IL-15 agonists in influenza vaccination strategies. The gene discussed is IL15; the disease is influenza.